Latest filing published 06 Jul 2026 for Ionis Pharmaceuticals INC, €404k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joseph Klein III, listed as senior executive, appears in our data through filings on Ionis Pharmaceuticals Inc shares, published by SEC (Form 4). The record holds 19 filings, for trades running from 15 July 2021 to 1 July 2026.
On the market, this insider has only sold: 8 sales, €2.6M in total. The rest of the record consists of 11 option exercises. In 2026 alone, the filings show no purchases and 4 sales.
The newest entry dates from 6 July 2026: an option exercise of €404k, in Ionis Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations